MRAP2 mice lack the early-onset hyperphagia of MC4R knockout mice, and humans with MRAP2 genetic variants exhibit hyperglycaemia, hypertension and high blood cholesterol more frequently than those with MC4R mutations (6). Here, MC4R is linked to hypertensive disorder.